Para citar este trabalho use um dos padrões abaixo:
The existing therapeutic arsenal for the treatment of pain and/or inflammation mainly involves opioid analgesics, non-steroidal anti-inflammatory drugs ( NSAIDs ) and glucocorticoids ( GCs ). These are far from ideal, since there are many adverse events caused by them. These are the main reasons for abandoning therapy with these classes of drugs, causing various damages to the health of individuals and compromising the effectiveness of the process. Therefore, the discovery of new drugs that induce fewer adverse events and are more effective is relevant for patient adherence to treatment, for the success of therapy and for the development of science. Researchers are increasingly using molecular design in the search for new drugs that can be used to treat pain and inflammation. Since it involves changes in the chemical structure of compounds, improving their potency and effectiveness. In addition, the aim is to reduce adverse effects, considering their possible toxic effects and the degree of stability in body tissues and fluids. In this perspective, the present work deals with the synthetic hybrid compound derived from the union of triclosan with ketoprofen, which is a molecule with potential analgesic and/or anti-inflammatory activity, with the aim of enhancing the possible therapeutic effects of the original molecules, improve your activity profile and suppress or mitigate deleterious effects.
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
Esse proceedings é identificado por um DOI , para usar em citações ou referências bibliográficas. Atenção: este não é um DOI para o jornal e, como tal, não pode ser usado em Lattes para identificar um trabalho específico.
Verifique o link "Como citar" na página do trabalho, para ver como citar corretamente o artigo